Document:

EX-4.1.3

 

Exhibit 4.1.3

 

LUCENT TECHNOLOGIES INC.

AND

THE BANK OF NEW YORK,

as Trustee

 

SECOND SUPPLEMENTAL INDENTURE

Dated as of November 30, 2006

 

Supplement to Indenture Dated as of June 4, 2003

 

 

 

     SECOND SUPPLEMENTAL INDENTURE, dated as of November 30, 2006 (the “Supplemental
Indenture”), among LUCENT TECHNOLOGIES INC., a Delaware corporation (the “Company”) and
THE BANK OF NEW YORK, a New York banking corporation, as trustee (the “Trustee”).

RECITALS

     WHEREAS, the Company and the Trustee have entered into that Indenture, dated as of June 4,
2003 (as supplemented by the First Supplement (as defined below) the “Indenture”), which
provided for the issuance of one or more series of securities (the “Securities”);

     WHEREAS, the Company and the Trustee have entered into that First Supplemental Indenture,
dated as of June 4, 2003 (the “First Supplement”), which provided for the issuance of the
Company’s 2 3/4% Series A Convertible Senior Debentures due 2023 (the “Series A Debentures”) and the
Company’s 2 3/4% Series B Convertible Senior Debentures due 2025 (the “Series B Debentures”,
and together with the Series B Debentures, the “Debentures”);

     WHEREAS, pursuant to the terms of the First Supplement, the Debentures were convertible into
shares of common stock, par value $0.01, of the Company (“Common Stock”);

     WHEREAS, pursuant to an Agreement and Plan of Merger, dated as of April 2, 2006 (the
“Merger Agreement”), by and among the Company, Alcatel, a société anonyme organized under
the laws of the Republic of France (“Alcatel”), and Aura Merger Sub, Inc., a Delaware
corporation and a wholly owned subsidiary of Alcatel (“Merger Sub”), Merger Sub will be
merged with and into the Company, with the Company continuing as the surviving corporation (the
“Merger”);

     WHEREAS, Alcatel will be renamed “Alcatel Lucent” upon effectiveness of the Merger;

     WHEREAS, as a result of the Merger, each share of Common Stock outstanding immediately prior
to the effective time of the Merger (the “Effective Time”) shall, except as provided in
Section 1.02(a)(i) of the Merger Agreement with respect to shares of Common Stock held by the
Company as treasury stock or held by Alcatel or Merger Sub immediately prior to the Effective Time,
be converted into the right to receive 0.1952 of an ADS (as defined in the Merger Agreement, an
“ADS”), and cash in lieu of fractional ADSs pursuant to Section 1.06 of the Merger
Agreement;

     WHEREAS, each ADS is an American Depository Share of Alcatel representing one (1) ordinary
share, nominal value €2.00 per share, of Alcatel (an “Alcatel Ordinary Share”);

     WHEREAS, the Merger constitutes a Conversion Rate Fundamental Change (as defined in the First
Supplement) pursuant to the terms of Section 1.10(f)(v) of the First Supplement;

     WHEREAS, pursuant to Section 1.10(f)(v) of the First Supplement, as a result of the Merger,
the Company is required to execute and deliver to the Trustee a supplemental

 

 

indenture providing (i) that the Debentures shall be convertible into the ADSs and cash in
lieu of fractional ADSs and (ii) for adjustments which shall be as nearly equivalent as practicable
to the adjustments provided for in Section 1.10 of the First Supplement;

     WHEREAS, Section 9.01 of the Indenture provides that the Company and the Trustee may amend or
supplement the Indenture or the Securities without the Consent of any Holder to make any change
that does not adversely affect the rights of any Holder;

     WHEREAS, the amendments contemplated herein do not and will not adversely affect the rights of
any Holders; and

     WHEREAS, the Company has complied with all conditions precedent provided for in the Indenture
relating to this Supplemental Indenture.

     NOW, THEREFORE, for and in consideration of the premises and other valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby,
it is hereby agreed between the Company and the Trustee, for the equal and proportionate benefit of
the respective holders of Debentures from time to time, as follows:

ARTICLE I

DEFINITIONS

     Section 1.1 Definition of Terms. Capitalized terms used and not otherwise defined
herein have the respective meanings assigned to such terms in the Indenture.

ARTICLE II

CONCERNING THE MERGER

     Section 2.1. Conversion Privilege. Pursuant to Section 1.10 of the First Supplement,
from and after the Effective Time, any right of a Holder to convert Debentures into Common Stock
shall be changed into the right to convert such Debentures into (i) 58.4431 ADSs per $1,000
principal amount of Debentures for Series A Debentures and 62.5641 ADSs per $1,000 principal amount
of Debentures for Series B Debentures (the “Stock Consideration”), and (ii) in lieu of any
fractional ADSs otherwise receivable pursuant to clause (i) hereof, cash in lieu of such fractional
ADSs in an amount that would have been paid in lieu of such amount of fractional ADSs pursuant to
Section 1.06 of the Merger Agreement (the “Cash Consideration”, and together with the Stock
Consideration, the “Conversion Consideration”), subject to further adjustments which shall
be as nearly equivalent as may be practicable to the adjustments provided for in Section 1.10 of
the First Supplement.

     Section 2.2. References to the Company and to Common Stock.

     (a) Subject to the other provisions of this Supplemental Indenture, all references in the
First Supplement to Common Stock shall be deemed to be references to the Conversion Consideration,
ADSs or Alcatel Ordinary Shares, to the extent necessary to give effect to Section 1.10(f)(v) of
the First Supplement.

     (b) Subject to the other provisions of this Supplemental Indenture, all

 

 

references in the First Supplement to the Company shall be deemed to be references to Alcatel
Lucent to the extent necessary to give effect to Section 1.10(f)(v) of the First Supplement.

     Section 2.3. Reservation of Shares. The Company hereby (i) agrees to cause (A)
Alcatel Lucent to reserve and keep available out of its authorized but unissued capital stock,
solely for the purpose of issuance upon conversion of Debentures as provided in this Supplemental
Indenture, a number of shares of Alcatel Ordinary Shares sufficient to issue the Stock
Consideration upon conversion of all outstanding Debentures (B) to be issued and delivered in
accordance with this Supplemental Indenture, the Stock Consideration and the Cash Consideration
upon conversion of any Debenture and (ii) warrants that all ADSs and the underlying Alcatel
Ordinary Shares that may be issued upon the conversion of any Debenture, when so issued, shall be
duly authorized, validly issued, fully paid and, with respect to the ADSs, nonassessable.

ARTICLE III

ACCEPTANCE OF SUPPLEMENTAL INDENTURE

     Section 3.1. Acceptance. The Trustee hereby accepts this Supplemental Indenture and
agrees to perform the same under the terms and conditions set forth in the Indenture.

ARTICLE IV

MISCELLANEOUS

     Section 4.1. Effectiveness of the Supplemental Indenture. This Supplemental Indenture
shall be effective as of the Effective Time.

     Section 4.2. Effect of Supplemental Indenture. Upon the execution and delivery of
this Supplemental Indenture by the Company and the Trustee, the Indenture shall be supplemented and
amended in accordance herewith, and this Supplemental Indenture shall form a part of the Indenture
for all purposes, and every holder of Debentures heretofore or hereafter authenticated and
delivered under the Indenture shall be bound thereby.

     Section 4.3. Indenture Remains in Full Force and Effect. Except as supplemented or
amended hereby, all provisions in the Indenture shall remain in full force and effect.

     Section 4.4. Incorporation of Indenture. All the provisions of this Supplemental
Indenture shall be deemed to be incorporated in, and made a part of, the Indenture; and the
Indenture, as supplemented and amended by this Supplemental Indenture, shall be read, taken and
construed as one and the same instrument.

     Section 4.5. Headings. The headings of the Articles and Sections of this Supplemental
Indenture are inserted for convenience of reference and shall not be deemed to be a part thereof.

 

 

     Section 4.6. Counterparts. This Supplemental Indenture may be executed in any number
of counterparts, each of which so executed shall be deemed to be an original, but all such
counterparts shall together constitute but one and the same instrument.

     Section 4.7. Conflict with Trust Indenture Act. If any provision of this Supplemental
Indenture limits, qualifies or conflicts with any provision of the Trust Indenture Act that is
required under the Trust Indenture Act to be part of and govern any provision of this Supplemental
Indenture, such provision of the Trust Indenture Act shall control. If any provision of this
Supplemental Indenture modifies or excludes any provision of the Trust Indenture Act that may be so
modified or excluded, the provision of the Trust Indenture Act shall be deemed to apply to the
Indenture as so modified or to be excluded by this Supplemental Indenture, as the case may be.

     Section 4.8. Successors and Assigns. All covenants and agreements in this
Supplemental Indenture by the Company shall bind its successors and assigns, whether so expressed
or not.

     Section 4.9 Separability Clause. In case any provision in this Supplemental Indenture
shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the
remaining provisions shall not in any way be affected or impaired thereby.

     Section 4.10 Benefits of Supplemental Indenture, Etc. Nothing in this Supplemental
Indenture, express or implied, shall give to any Person, other than the parties hereto and thereto
and their successors hereunder, any benefit or any legal or equitable right, remedy or claim under
this Supplemental Indenture, the Indenture or the Debentures.

     Section 4.11 Recitals. The recitals contained herein are made by the Company, and the
Trustee assumes no responsibility for their correctness. The Trustee makes no representations as
to the validity or sufficiency of this Supplemental Indenture.

     Section 4.12 Certain Duties and Responsibilities of the Trustee. In entering into
this Supplemental Indenture, the Trustee shall be entitled to the benefit of every provision of the
Indenture relating to the conduct or affecting the liability of or affording protection to the
Trustee, whether or not elsewhere herein so provided, and the Trustee shall not be under any
responsibility to determine the correctness of any provisions contained in this Supplemental
Indenture relating either to the kind or amount of shares of stock or securities or property
(including cash) receivable by holders of Debentures upon the conversion of their Debentures or to
any adjustment to be made with respect thereto.

     Section 4.13 No Security Interest Created. Nothing in this Supplemental Indenture,
express or implied, shall be construed to constitute a security interest under the Uniform
Commercial Code or similar legislation, as now or hereafter enacted and in effect, in any
jurisdiction in which property of the Company and its Subsidiaries is located.

     Section 4.14 Governing Law. This Supplemental Indenture shall be governed by and
construed in accordance with the laws of the State of New York, without regard to the conflict of
laws provisions thereof.

 

 

[ SIGNATURE PAGES FOLLOW]

 

 

     IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and attested, all as of the date and year first written above.

	 	 	 	 	 
	 	LUCENT TECHNOLOGIES INC.

 	 
	 	By:  	John A. Kritzmacher
 	 
	 	 	Name:  	John A. Kritzmacher 	 
	 	 	Title:  	Chief Financial Officer 	 
	 

	 	 	 	 	 
	 	THE BANK OF NEW YORK, as Trustee

 	 
	 	By:  	Julie Salovitch-Miller
 	 
	 	 	Name:  	Julie Salovitch-Miller 	 
	 	 	Title:  	Vice PresidentEX-4.1.4

 

Exhibit 4.1.4

LUCENT TECHNOLOGIES INC.,

AND

THE BANK OF NEW YORK,

as Trustee

 

THIRD SUPPLEMENTAL INDENTURE

Dated as of December [__], 2006

 

Supplement to Indenture Dated as of June 4, 2003

 

 

 

 

     THIRD SUPPLEMENTAL INDENTURE, dated as of December [___], 2006 (the “Supplemental
Indenture”), among LUCENT TECHNOLOGIES INC., a Delaware corporation (the “Company”),
and THE BANK OF NEW YORK, a New York banking corporation, as trustee (the “Trustee”).

RECITALS

     WHEREAS, the Company and the Trustee have entered into that Indenture, dated as of June 4,
2003 (as supplemented by the First Supplement (as defined below) and the Second Supplement (as
defined below), the “Indenture”), which provided for the issuance of one or more series of
securities (the “Securities”);

     WHEREAS, the Company and the Trustee have entered into that First Supplemental Indenture,
dated as of June 4, 2003 (the “First Supplement”), which provided for the issuance of the
Company’s 2 3⁄4% Series A Convertible Senior Debentures due 2023 (the “Series A Debentures”)
and the Company’s 2 3⁄4% Series B Convertible Senior Debentures due 2025 (the “Series B
Debentures”, and together with the Series A Debentures, the “Debentures”);

     WHEREAS, pursuant to an Agreement and Plan of Merger, dated as of April 2, 2006 (the
“Merger Agreement”), by and among the Company, Alcatel, a societe anonyme organized under
the laws of the Republic of France, and Aura Merger Sub, Inc., a Delaware corporation and a direct,
wholly owned subsidiary of Alcatel (“Merger Sub”), Merger Sub merged with and into the
Company on November 30, 2006, with the Company continuing as the surviving corporation (the
“Merger”);

     WHEREAS, following consummation of the Merger, the Company is a wholly owned subsidiary of
Alcatel and Alcatel changed its name to Alcatel Lucent (“Alcatel Lucent”);

     WHEREAS, the Company and the Trustee have entered into that Second Supplemental Indenture
dated as of November 30, 2006 (the “Second Supplement”) as required by the terms of the
Indenture in connection with the consummation of the Merger (as defined below);

     WHEREAS, the Board of Directors of Alcatel Lucent has determined it to be in the best interest
of Alcatel Lucent to guaranty the principal of, premium, if any, interest on, and all other
monetary obligations arising under the Debentures;

     WHEREAS, the Company desires to execute and deliver this Supplemental Indenture (i) to amend
the Indenture to provide that the reports and other information required to be provided by the
Company and in respect of the Company may instead be provided only with respect to Alcatel Lucent,
(ii) to amend the Indenture to provide that the holders of the Debentures shall receive an
adjustment to the Conversion Rate (as defined in the First Supplement) in the event the Parent (as
defined herein) pays any dividend or distribution in cash during the fiscal year of the Parent in
excess of a specified threshold (collectively the items specified in clause (i) and (ii) being the
“Consent Amendments”), (iii) to amend the Indenture to increase the interest rate payable
in the respect of the Debentures from 2 3⁄4% per annum to 2.875% per annum, (iv) to increase the
Conversion Rate in effect immediately prior to the date

2

 

hereof,
(v) to amend the Indenture to allow the Company to set-off any
withholding due from a holder against amounts due to such holder and
(vi) to add certain defined terms and related text in the Indenture;

     WHEREAS, the Board of Directors of the Company has determined it to be in the best interest of
the Company to make the Consent Amendments and the other amendments to the Indenture;

     WHEREAS, Section 9.02 of the Indenture provides that the Company and the Trustee may amend or
supplement the Indenture or the Securities to effect the Consent Amendments with the written
consent of the Holders of at least a majority in principal amount of the Securities of each Series
then outstanding (the “Required Consent”);

     WHEREAS, the Company has obtained the consent of the holders of a majority in principal
amount of the Series [___] Debentures (a “Required Series Consent”); and

     WHEREAS, pursuant to Section 9.02 of the Indenture, upon receipt of a Required Series Consent,
the Company and the Trustee are authorized to execute this Supplemental Indenture, which shall
become operative upon receipt of a Required Consent.

     NOW, THEREFORE, for and in consideration of the premises and other valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, and intending to be legally bound hereby,
it is hereby agreed between the Company and the Trustee, for the equal and proportionate benefit of
the respective Holders from time to time, as follows:

ARTICLE I

DEFINITIONS

     Section 1.1. Definition of Terms. Capitalized terms used and not otherwise defined
herein have the respective meanings assigned to such terms in the Indenture.

ARTICLE II

AMENDMENTS

     Section 2.1. Section 1.01 of the Indenture is amended to delete the definitions of
“Conversion Price” and “Interest” in their entirety and substitute in lieu thereof
the following:

     “Conversion Price” means, as of the Third Supplemental Indenture Date, $1,000 divided
by the applicable Conversion Rate, (i) initially, in the case of the Series A Debentures, $16.75
and (ii) initially, in the case of the Series B Debentures, $15.35.

     “Interest” means during the period (i) commencing on the Original Issue Date to but
excluding the Third Supplemental Indenture Date, an annual rate of 2 3⁄4% of the principal amount of
the Series A Debentures and 2 3⁄4% of the principal amount of the Series B Debentures and (ii)
commencing on the Third Supplemental Indenture Date, an annual rate of 2.875% of the principal
amount of the Series A Debentures and 2.875% of the principal amount of the Series B Debentures, in
each case, plus defaulted interest, if any.

3

 

     Section 2.2. Section 1.01 of the First Supplement is amended by adding in clause (c) of the
definition of “Current Market Price” the following “and (viii)” immediately after the reference to
“Section 1.10(f)(vii)” contained therein.

     Section 2.3. Section 1.01 of the Indenture is further amended to include the following
definitions in their proper alphabetical location:

     “ADS” means an American Depository Share of Alcatel Lucent representing, as of the
Third Supplemental Indenture Date, one (1) Alcatel Lucent Ordinary Share.

     “Alcatel Lucent Ordinary Share” means an ordinary share, nominal value €2.00 per
share, of Alcatel Lucent.

     “Beneficial Owner” has the meaning assigned to such term in Rule 13d-3 and Rule 13d-5
under the Exchange Act, except that in calculating the beneficial ownership of any particular
“person,” as such term is used in Section 13(d)(3) of the Exchange Act, such “person” shall be
deemed to have beneficial ownership of all securities that such “person” has the right to acquire,
whether such right is currently exercisable or is exercisable only upon the occurrence of a
subsequent condition.

     “Dividend Threshold Amount” means €0.08, appropriately adjusted from time to time for
any stock dividends on, subdivisions or combinations of, or similar transactions with respect to,
the Common Stock.

     “Parent” means any person (as such term is used in Sections 13(d) and 14(d) of the
Exchange Act and the regulations thereunder) who is or becomes the Beneficial Owner, directly or
indirectly, of more than 50% of the total voting stock or total common equity of the Company.

     “Parent Guaranty” means a guaranty by a Parent (whether or not subordinated to the
Parent’s senior debt) of the principal of, premium, if any, interest on, and all other monetary
obligations arising under the Debentures.

     “Third Supplement Conversion Rate Adjustment” has the meaning provided in Section 2.7
of the Third Supplemental Indenture.

     “Third Supplemental Indenture” means the Third Supplemental Indenture dated as of
December [_________], 2006.

     “Third Supplemental Indenture Date” means the date of effectiveness of the Third
Supplemental Indenture.

     Section 2.4. Section 4.02 of the Indenture is amended by inserting the following text as a new
paragraph at the end of Section 4.02:

     Notwithstanding the foregoing, if the Parent executes and delivers a Parent Guaranty, the
Parent may furnish to the Holders copies of its annual report and the information, documents and
other reports (without including the condensed consolidating footnote

4

 

contemplated by Rule 3-10 of Regulation S-X promulgated under the Securities Act) that the
Parent is required to file pursuant to Sections 13 and 15(d) of the Exchange Act in lieu of those
required to be furnished by the Company. At such time as the Parent Guaranty is released or
terminated, the Parent shall no longer be obligated to provide the reports and information provided
for in this paragraph.

     Section 2.5. Section 1.03 of the First Supplement is amended by deleting in its entirety the
second sentence thereof and substituting in lieu thereof:

     The unpaid principal amount of the Series A Debentures and the unpaid principal amount of the
Series B Debentures shall bear interest at a rate equal to during the period (i) commencing on the
Original Issue Date to but excluding the Third Supplemental Indenture Date, of 2 3⁄4% per annum and
(ii) commencing on the Third Supplemental Indenture Date, 2.875%, in each case until paid or duly
provided for, and such interest shall accrue from the commencement of the applicable period or from
the most recent Interest Payment Date to which interest has been paid or duly provided for.

     Section 2.6. Section 1.10(f) of the First Supplement is amended by inserting the following
“and Section 1.10(f)(viii)” immediately after the reference to “Section 1.10(f)(vii)” in Section
1.10(f)(vii).

     Section 2.7. Section 1.10(f) of the First Supplement is further amended by inserting the
following text as new clauses (viii) and (ix) at the end of Section 1.10(f):

     (viii) Cash dividends or distributions. In case the Parent pays a dividend or makes a
distribution in all cash on the Common Stock to all holders of Common Stock during any fiscal year
(or portion thereof) of Parent after the Third Supplemental Indenture Date for which an adjustment
has not been made previously pursuant to this Section 1.10(f)(viii) and Section 1.10(f)(vii) in an
aggregate amount that, together with all other all-cash dividends or distributions made during such
fiscal year (or portion thereof) that exceeds, on a per share Common Stock basis, the Dividend
Threshold Amount (excluding, any such cash dividend or distribution in connection with liquidation,
dissolution or winding up of the Parent) the Conversion Rate in effect immediately before the close
of business on the day that the ADSs trade ex-distribution will be adjusted by dividing (A) the
Conversion Rate by (B) a fraction, the numerator of which will be the Current Market Price of the
ADSs and the denominator of which will be the Current Market Price of the ADSs plus the amount per
share of such dividend or distribution payable to the holders of
Alcatel Lucent Ordinary Shares in excess of the Dividend
Threshold Amount, and, if applicable, converted into Dollars using the euro/US dollar “noon buying
rate” in New York certified by the New York Federal Reserve Bank on the date of payment of such
dividend or distribution. If the prior consent of
the Parent’s shareholders would be required for the issuance of any additional shares of ADSs
issuable as a result of the adjustment provided for in this Section 1.10(f)(viii) and such consent
has not been received as of the relevant Conversion Date, the Company shall have at its option the
right to deliver cash, ADSs or any combination of cash and ADSs for the current market value of such
additional shares. The current market value of such additional shares of ADSs shall be determined
to the nearest 1/10,000th of a share and shall be the Sale Price of a share of ADS on
the Trading Day immediately preceding the relevant Conversion Date. If the shareholders’

5

 

consent shall have been received prior to the relevant Conversion Date, the Company shall not
have the option of delivering cash for such additional shares of ADSs, other than in respect of any
fractional shares issuable upon such conversion.

     (ix) Withholding taxes. If the Company pays U.S. federal withholding taxes on behalf
of a non-U.S. Holder as a result of the Third Supplement Conversion Rate Adjustment or any
adjustment provided for in Section 1.10(f)(viii), the Company may, at its option, set off such
payments against payments to such non-U.S. Holder with respect to the Debentures held by such
Holder or the ADSs issuable to such Holder upon conversion.

     Section 2.8. Section 1.12 of the First Supplement is amended by deleting the first sentence of
such Section in its entirety and substituting in lieu thereof the following:

     Except in connection with shares of Common Stock issuable in respect of any adjustments made
pursuant to Section 1.10(f)(viii), the Company shall at all times reserve and keep available, free
from preemptive rights, out of its authorized but unissued shares or shares held in treasury,
sufficient shares of Common Stock to permit the conversion of all the outstanding Debentures as
such Debentures are presented for conversion from time to time.

ARTICLE III

THE CONVERSION RATE

     Section 3.1. Conversion Rate. Notwithstanding anything to the contrary contained in
the Indenture, the First Supplement, the Second Supplement or the Global Securities, as of the
Third Supplemental Indenture Date, the Conversion Rate shall be deemed to be (i) in respect of the
Series A Debentures, 59.7015 ADSs per $1,000 principal amount of the Series A Debentures and (ii)
in respect of the Series B Debentures, 65.1465 ADSs per $1,000 principal amount of the Series B
Debentures (collectively, the “Third Supplement Conversion Rate Adjustment”), in each case,
subject to adjustment in certain events described in the Indenture.

     Section 3.2. Calculation of Conversion Rate Adjustments. Notwithstanding anything to
the contrary contained herein or in the Indenture, the First Supplement, the Second Supplement or
the Global Securities, to the extent any adjustment is required to made to the Conversion Rate as a
result of the provisions of Section 1.10 of the First Supplement (as further supplemented by the
Second Supplement and this Supplemental Indenture), such adjustment shall be made on the first
Business Day that calculation of such adjustment may be reasonably determined, which date may occur
following the date of the event giving rise to such adjustment.

     Section 3.3. References to Common Stock. Subject to the provisions of the Indenture,
the First Supplement, the Second Supplement and this Supplemental Indenture, all references to
Common Stock in the First Supplement and this Supplemental Indenture shall be deemed to be
references to the Conversion Consideration (as defined in the Second Supplement), ADSs or Alcatel
Lucent Ordinary Shares, to the extent necessary to give effect to Section 1.10(f)(v) of the First
Supplement.

6

 

ARTICLE IV

ACCEPTANCE OF SUPPLEMENTAL INDENTURE

     Section 4.1. Acceptance. Upon receipt of a Required Series Consent, the Trustee
hereby accepts this Supplemental Indenture and agrees to perform the same under the terms and
conditions set forth in the Indenture upon receipt of the Required Consent.

ARTICLE V

MISCELLANEOUS

     Section 5.1. Effectiveness of the Supplemental Indenture. This Supplemental Indenture
shall be effective as to all series of Debentures on the date that (i) the Required Consent is
obtained and (ii) the Company and the Trustee have executed this Supplemental Indenture. If upon
receipt of a Required Series Consent, the Trustee accepts and executes this Supplemental Indenture
in accordance with Section 4.1 and the Required Consent is not
thereafter obtained in accordance with the terms of the consent solicitation for the Required Consent, this
Supplemental Indenture shall be null and void.

     Section 5.2. Effect of Supplemental Indenture. Upon the effectiveness of this
Supplemental Indenture, (i) the Indenture shall be supplemented and amended in accordance herewith,
(ii) this Supplemental Indenture shall form a part of the Indenture for all purposes, and every
holder of Debentures heretofore or hereafter authenticated and delivered under the Indenture shall
be bound thereby, (iii) the Securities shall be designated as the Company’s 2.875% Series A
Convertible Senior Debentures due 2023 and the Company’s 2.875% Series B Convertible Senior
Debentures due 2025, respectively and (iv) subject to the amendments provided for in this
Supplement Indenture, all references in the First Supplement and the Global Securities to 2 3⁄4%
shall be deemed to be references to 2.875%.

     Section 5.3. Indenture Remains in Full Force and Effect. Except as supplemented or
amended hereby, all provisions in the Indenture shall remain in full force and effect.

     Section 5.4. Incorporation of Indenture. All the provisions of this Supplemental
Indenture shall be deemed to be incorporated in, and made a part of, the Indenture; and the
Indenture, as supplemented and amended by this Supplemental Indenture, shall be read, taken and
construed as one and the same instrument.

     Section 5.5. Headings. The headings of the Articles and Sections of this Supplemental
Indenture are inserted for convenience of reference and shall not be deemed to be a part thereof.

     Section 5.6. Counterparts. This Supplemental Indenture may be executed in any number
of counterparts, each of which so executed shall be deemed to be an original, but all such
counterparts shall together constitute but one and the same instrument.

     Section 5.7. Conflict with Trust Indenture Act. If any provision of this Supplemental
Indenture limits, qualifies or conflicts with any provision of the Trust Indenture Act that is
required under the Trust Indenture Act to be part of and govern any provision of this Supplemental
Indenture, such provision of the Trust Indenture Act shall control. If any provision

7

 

of this Supplemental Indenture modifies or excludes any provision of the Trust Indenture Act
that may be so modified or excluded, the provision of the Trust Indenture Act shall be deemed to
apply to the Indenture as so modified or to be excluded by this Supplemental Indenture, as the case
may be.

     Section 5.8. Successors and Assigns. All covenants and agreements in this
Supplemental Indenture by the Company and Lucent shall bind their respective successors and
assigns, whether so expressed or not.

     Section 5.9. Separability Clause. In case any provision in this Supplemental
Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of
the remaining provisions shall not in any way be affected or impaired thereby.

     Section 5.10. Benefits of Supplemental Indenture, Etc. Nothing in this Supplemental
Indenture, express or implied, shall give to any Person, other than the parties hereto and thereto
and their successors hereunder, any benefit or any legal or equitable right, remedy or claim under
this Supplemental Indenture, the Indenture or the Debentures.

     Section 5.11. Recitals. The recitals contained herein are made by the Company and the
Trustee assumes no responsibility for their correctness. The Trustee makes no representations as
to the validity or sufficiency of this Supplemental Indenture.

     Section 5.12. Certain Duties and Responsibilities of the Trustee. In entering into
this Supplemental Indenture, the Trustee shall be entitled to the benefit of every provision of the
Indenture relating to the conduct or affecting the liability of or affording protection to the
Trustee, whether or not elsewhere herein so provided.

     Section 5.13. No Security Interest Created. Nothing in this Supplemental Indenture,
express or implied, shall be construed to constitute a security interest under the Uniform
Commercial Code or similar legislation, as now or hereafter enacted and in effect, in any
jurisdiction in which property of the Company and its Subsidiaries is located.

     Section 5.14. Governing Law. This Supplemental Indenture shall be governed by and
construed in accordance with the laws of the State of New York, without regard to the conflict of
laws provisions thereof.

[SIGNATURE PAGES FOLLOW]

8

 

     IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and attested, all as of the date and year first written above.

	 	 	 	 	 
	 	LUCENT TECHNOLOGIES INC.

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:  	 	 
	 

	 	 	 	 	 
	 	THE BANK OF NEW YORK, as Trustee

 	 
	 	By:  	 	 
	 	 	Name:  	 	 
	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00114-of-00352.parquet"}]]